Email Updates

You are here

Home

AVAC's Blog: P-Values

  • Webinar: What do women want in multipurpose technologies?

    Multipurpose Prevention Technologies are a fast-growing area in women’s sexual and reproductive health. AVAC and CAMI Health co-hosted a webinar: MPT Acceptability in Uganda, Nigeria, and South Africa. Researchers from Ipsos discussed methods and key findings from the market research study that assessed the acceptability of multipurpose options among women in Uganda, Nigeria and South Africa.

    November 13, 2014
    Multipurpose Prevention Technologies

  • Guest Blog by UNAIDS' Chris Collins — Fast Track: New AIDS targets and the urgency for action

    Without ramped up delivery of lifesaving treatment and targeted prevention in the next five years, along with advances in non-discrimination and human rights that make these services possible, the AIDS epidemic will remain a serious global health threat as far as we can see.

    November 12, 2014
    Combination Prevention
    Chris Collins

  • HIV R4P Conference Charts Way Forward for Biomedical Prevention

    The recent HIV Research for Prevention (HIV R4P) meeting—the first to bring all biomedical HIV prevention research under one roof—is now available for viewing via webcast online. WhatsUpHIV, the “live blog” from the conference features posts from advocates, African journalists and researchers. AVAC also provided daily summaries from the meeting and recently hosted a post-R4P webinar.

    November 7, 2014
    Combination Prevention

  • Evidence for PrEP builds

    Recent announcements from two ongoing PrEP trials, PROUD and IPERGAY, add to the body of evidence that TDF/FTC (Truvada) for HIV prevention is safe and effective. Check out the coverage including what, if anything, the news means for PrEP access in Europe, the plans for the trials moving forward and more.

    November 7, 2014
    PrEP

  • November 6 Webinar- The State of the HIV Prevention Union: The Road from R4P

    AVAC’s November 6 webinar on “The State of the HIV Prevention Union” will build on last week’s HIV Research for Prevention (R4P) conference—the first meeting to gather all the fields of biomedical prevention research under one roof. From broadly-neutralizing antibodies to building trust between trial participants and research teams—R4P had it all. Register now to keep the conversation going.

    November 4, 2014
    Combination Prevention

  • Leaders in the field discuss progress towards an HIV vaccine at CSIS event

    The Center for Strategic and International Studies hosted “Ending Epidemics Through Technology: Developing an HIV Vaccine,” featuring a keynote presentation by Dr. Anthony Fauci, Director of the US National Institute of Allergy and Infectious Diseases, which was followed by a discussion with Margie McGlynn, President and CEO of the International AIDS Vaccine Initiative and Mitchell Warren, Executive Director of AVAC.

    November 4, 2014
    HIV Vaccine

  • HIV R4P Conference Day 4 Snapshot

    Greetings from the fourth and final day of the HIV R4P conference! Read highlights from the conference and information about the individual sessions. And we are tweeting all the latest news and photos

    October 31, 2014
    Combination Prevention

  • HIV R4P Conference Day 3 Snapshot

    Greetings from the third day of the HIV R4P conference! Each day AVAC will be providing a dispatch with highlights from the conference. Read on for information about the plenary speeches and individual sessions. And we are tweeting all the latest news and photos

    October 30, 2014
    Combination Prevention

  • Arm advocates with the appropriate facts so that they can drive change in their own countries

    Charles Brown reflects on the important role of advocates in prevention research and what they need to succeed. This post was written for the WhatsUpHIV blog, which reported in real time on the 2014 HIV Research for Prevention conference in Cape Town, South Africa.

    October 30, 2014
    PrEP
    Charles Brown, 2014 AVAC Advocacy Fellow

  • Why we young women had to resort to putting up the Visible Panty Line

    Yvette Raphael critiques researchers' efforts to engage young women at the 2014 HIV Research for Prevention (HIV R4P) conference. She challenges how researchers talk about women "lying" about adherence and expresses frustration at the difficulty of getting these researchers to participate in a conversation about this. This post was written for the WhatsUpHIV blog, which reported in real time on the 2014 HIV Research for Prevention conference in Cape Town, South Africa.

    October 30, 2014
    Microbicides, PrEP
    Yvette Raphael, 2014 AVAC Advocacy Fellow

Pages

view more